awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33441053-5F2DDA90-0C9B-428D-A54B-07E6A4468068
Q33441053-5F2DDA90-0C9B-428D-A54B-07E6A4468068
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33441053-5F2DDA90-0C9B-428D-A54B-07E6A4468068
Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
P2860
Q33441053-5F2DDA90-0C9B-428D-A54B-07E6A4468068
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33441053-5F2DDA90-0C9B-428D-A54B-07E6A4468068
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
78a74865074bf7e03fc1fdd507b297fa6e77e42a
P2860
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.